Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 8 | 2021 | 672 | 1.970 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 11 | 2021 | 2989 | 1.520 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2019 | 1182 | 0.770 |
Why?
|
| Thorax | 1 | 2020 | 506 | 0.660 |
Why?
|
| Pulmonary Artery | 2 | 2021 | 1895 | 0.650 |
Why?
|
| Lung | 7 | 2020 | 9617 | 0.640 |
Why?
|
| P-Selectin | 1 | 2019 | 613 | 0.630 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 724 | 0.620 |
Why?
|
| Air Pollution | 4 | 2019 | 1985 | 0.580 |
Why?
|
| Emphysema | 1 | 2017 | 211 | 0.570 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2017 | 802 | 0.540 |
Why?
|
| Auditory Perception | 1 | 2019 | 514 | 0.530 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2021 | 20307 | 0.490 |
Why?
|
| Atherosclerosis | 3 | 2019 | 3183 | 0.450 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 735 | 0.440 |
Why?
|
| Respiratory Function Tests | 5 | 2021 | 1667 | 0.430 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 864 | 0.410 |
Why?
|
| Air Pollutants | 3 | 2019 | 2589 | 0.410 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1473 | 0.390 |
Why?
|
| Pulmonary Heart Disease | 1 | 2019 | 40 | 0.390 |
Why?
|
| Particulate Matter | 4 | 2019 | 2278 | 0.380 |
Why?
|
| Spirometry | 3 | 2019 | 858 | 0.340 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4668 | 0.330 |
Why?
|
| Vital Capacity | 3 | 2019 | 910 | 0.270 |
Why?
|
| Heart Ventricles | 4 | 2020 | 3839 | 0.270 |
Why?
|
| Disease Progression | 7 | 2021 | 13298 | 0.230 |
Why?
|
| E-Selectin | 1 | 2014 | 584 | 0.230 |
Why?
|
| Aspirin | 2 | 2018 | 3155 | 0.220 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 857 | 0.220 |
Why?
|
| Asthma | 1 | 2019 | 5831 | 0.200 |
Why?
|
| Auscultation | 1 | 2019 | 49 | 0.190 |
Why?
|
| Nitrogen Oxides | 2 | 2019 | 126 | 0.190 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4130 | 0.170 |
Why?
|
| Thrombocytosis | 1 | 2018 | 88 | 0.170 |
Why?
|
| Angiotensins | 1 | 2017 | 131 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1723 | 0.160 |
Why?
|
| Ozone | 2 | 2019 | 447 | 0.150 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 579 | 0.150 |
Why?
|
| Linear Models | 4 | 2019 | 6012 | 0.150 |
Why?
|
| Tomography | 1 | 2017 | 353 | 0.150 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 58752 | 0.150 |
Why?
|
| Carbon | 2 | 2019 | 657 | 0.140 |
Why?
|
| Middle Aged | 17 | 2021 | 215428 | 0.140 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 13595 | 0.130 |
Why?
|
| Aged | 14 | 2021 | 162592 | 0.120 |
Why?
|
| Sleep | 1 | 2019 | 4086 | 0.120 |
Why?
|
| Exercise | 2 | 2016 | 5269 | 0.110 |
Why?
|
| Humans | 22 | 2021 | 709431 | 0.100 |
Why?
|
| Male | 16 | 2021 | 351848 | 0.100 |
Why?
|
| United States | 8 | 2021 | 67177 | 0.100 |
Why?
|
| Forced Expiratory Volume | 2 | 2016 | 1722 | 0.100 |
Why?
|
| Organ Size | 2 | 2019 | 2320 | 0.100 |
Why?
|
| Prospective Studies | 6 | 2020 | 50734 | 0.100 |
Why?
|
| Motor Activity | 1 | 2010 | 2776 | 0.100 |
Why?
|
| Female | 16 | 2021 | 377269 | 0.100 |
Why?
|
| Dyspnea | 1 | 2017 | 1238 | 0.090 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 795 | 0.090 |
Why?
|
| Smoking | 3 | 2020 | 8940 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2017 | 6515 | 0.080 |
Why?
|
| Respiratory System | 1 | 2019 | 560 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2017 | 391 | 0.070 |
Why?
|
| Genotype | 1 | 2019 | 12955 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12517 | 0.060 |
Why?
|
| Actigraphy | 1 | 2016 | 445 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2020 | 39650 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 16161 | 0.060 |
Why?
|
| Polysomnography | 1 | 2019 | 1734 | 0.060 |
Why?
|
| Parasympathectomy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Mucociliary Clearance | 1 | 2020 | 70 | 0.050 |
Why?
|
| Hospitalization | 1 | 2019 | 9632 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 20587 | 0.050 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2020 | 115 | 0.050 |
Why?
|
| Inflammation | 1 | 2019 | 9948 | 0.050 |
Why?
|
| Endophenotypes | 1 | 2020 | 249 | 0.040 |
Why?
|
| Mortality | 1 | 2019 | 2794 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2020 | 441 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2020 | 880 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 465 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39394 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2015 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 724 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2020 | 773 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 11384 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12442 | 0.030 |
Why?
|
| Disease | 1 | 2020 | 705 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 4452 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2020 | 872 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7071 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1593 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2109 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2071 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 2929 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 212298 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3688 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6137 | 0.020 |
Why?
|
| Neutrophils | 1 | 2020 | 3865 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 29148 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 2970 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10744 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8053 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 10621 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 34096 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 71151 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 14054 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17347 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 22944 | 0.010 |
Why?
|
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_